The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem

Affiliations

¹ Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.
² Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France Département PM2 Plateforme de Métabolomique, APHP, Hôpital Saint Antoine, Peptidomique et dosage de Médicaments, Paris, France.
³ Service de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.
⁴ Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
⁵ Service de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.

Comment

Elodie Quévrain et al. Gut. 2016 May.

. 2016 May;65(5):882.

doi: 10.1136/gutjnl-2015-311094. Epub 2015 Dec 15.

¹ Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.
² Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France Département PM2 Plateforme de Métabolomique, APHP, Hôpital Saint Antoine, Peptidomique et dosage de Médicaments, Paris, France.
³ Service de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.
⁴ Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
⁵ Service de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.

No abstract available

Keywords: INFLAMMATORY BOWEL DISEASE; INTESTINAL BACTERIA.

Comment on

Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdez-Humarán LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Chatel JM, Trugnan G, Xavier R, Langella P, Sokol H, Seksik P. Quévrain E, et al. Gut. 2016 Mar;65(3):415-425. doi: 10.1136/gutjnl-2014-307649. Epub 2015 Jun 4. Gut. 2016. PMID: 26045134 Free PMC article.